With its robust mammalian cell-based biopharmaceutical manufacturing infrastructure and expertise, Yerlika has now extended its capabilities to offer CDMO (Contract Development and Manufacturing Organization) […]
Turning Another Dream into Reality: A Historic Milestone in Local Biotechnological API Production! We are proud to announce that we now produce, right here […]
Dr. Hasan Zeytin, CEO of Yerlika, recently shared insights into the company’s strategic vision and Türkiye’s ambitions in biopharmaceutical manufacturing during an exclusive interview […]
On January 9, 2025, the “Productive Healthcare” themed event, hosted by the Ministry of Health of the Republic of Türkiye and TÜSEB, marked significant […]
As Yerlika, we are proud to announce that we have achieved support for two significant biosimilar localization projects in the first term of TÜBİTAK’s […]